Tagged Articles

Xarelto 210 articles

Xarelto bleeding victim fights drugmakers’ motion to throw out case

A man suing Johnson & Johnson’s Janssen Pharmaceuticals and Bayer over Xarelto bleeding risks pushed back against the drug companies after they asked the judge overseeing the case in Philadelphia to drop the case because his prescribing doctor testified he did not read Xarelto’s safety label. Daniel Russell argued that the focus should not be on that doctor – Dr. Riple Hansalia – because he was simply continuing a prescription made by another physician – Dr. Ihab Girgis – the day before. Thus, Dr. Girgis should be considered the relevant prescriber under the law, Russell argued. Furthermore, Dr. Hansalia may ... Read More

J&J profits despite mounting Xarelto lawsuits

Johnson & Johnson told investors that it expects to rake in between $81 billion and $81.8 billion in profits for 2018, more than previously forecasted, and $20 billion in first-quarter sales – up 12.6 percent year-over-year, thanks in large part to its pharmaceutical unit. But one drug that fell under the company’s expectations was its blood thinner Xarelto. Xarelto posted a sales increase of 13 percent to $578 million, but missed the company’s estimate of $634 million. Johnson & Johnson blamed supply issues caused by Hurricane Maria and changes in access agreements with insurers. Despite these challenges, Xarelto gained 1.6 ... Read More

Janssen, Bayer ask judge to toss latest Xarelto side effects trial

Johnson & Johnson’s Janssen Pharmaceuticals and Bayer asked a Philadelphia judge to toss a case currently in trial blaming the drug companies for not adequately warning about bleeding risks with their blood thinner Xarelto, arguing that there is no evidence that the prescribing physician in the case would have given the plaintiff a different medication if stronger warnings had been on the label, because he testified he didn’t even read the drug’s label. As a result, Janssen and Bayer argued, the plaintiff doesn’t have a case. The trial involves the case of Daniel Russell, who in April 2013 had a ... Read More

Second Xarelto side effects trial underway in PA

Johnson & Johnson’s Janssen Pharmaceuticals and Bayer failed to warn doctors about the significantly increased risk of internal bleeding their blood thinner Xarelto posed to patients who were also taking other antiplatelet medications, attorneys for a man suing the companies said during opening arguments in the second trial in a mass tort program in Philadelphia County. In 2013, Plaintiff Daniel Russell had a stent placed to treat a blocked coronary artery. He also had an irregular heartbeat. At that time, he was prescribed two anti-platelet medications, aspirin and Plavix, to prevent blood clots. Soon after, his heart was shocked back ... Read More

Second Xarelto trial underway in Philadelphia County

The second case among more than 1,700 in a mass tort program in Philadelphia County Court of Common Pleas over claims that the blood thinner Xarelto caused seious harm to patients, is scheduled to go to trial this week. The trial involves the case of Daniel Russell, who was prescribed Xarelto in May 2013 to prevent strokes after he was hospitalized with a heart condition. Seven days into his Xarelto treatment, Russell suffered a gastrointestinal bleed. He claims his major bleeding event was caused by Xarelto because at the time he was prescribed the drug he was already taking two ... Read More

Approval of Xarelto antidote still hangs in the air

A novel drug that reverses the blood thinning abilities of newer anticoagulants called Factor Xa inhibitors could control serious bleeding in patients. If approved by drug regulators, it would be the first antidote on the market that can reverse the effects of Factor Xa inhibition when potentially life-threatening major bleeding events occur. The drug’s effectiveness was suggested by clinical trial results presented at the American College of Cardiology’s 67th Annual Scientific Session. Factor Xa inhibitors work by inhibiting a protein involved in the formation of blood clots. Drugs in this class include Xarelto and Eliquis. They are used to prevent ... Read More

1,200 Xarelto cases to be prepped for trial

U.S. District Judge Eldon Fallon has ordered more than 1,200 cases alleging Johnson & Johnson’s Janssen Pharmaceuticals and Bayer’s blood thinner Xarelto caused severe injuries to be prepared for trials in courts across the country. Half of the cases were assigned for discovery by the end of April. The second wave will be selected by Aug. 30. Johnson & Johnson and its subsidiary Janssen face about 22,900 cases. Bayer faces about 22,000. All claim that the drug makers did not adequately warn doctors or patients about the risks associated with their blockbuster anticoagulant. Xarelto has been linked to bleeding events ... Read More

Xarelto makers don’t want patients to amend complaint

A month before a new round of bellwether trials is scheduled to begin in a mass tort program involving the blood thinner Xarelto, drug makers Johnson & Johnson’s Janssen Pharmaceuticals and Bayer have asked a Pennsylvania judge not to allow a substantially amended master complaint because they say it would significantly prejudice them in presenting a logical defense. There are 1,700 Xarelto-related cases in the mass tort program in the Philadelphia County Court of Common Pleas. The new master complaint lays out general allegations regarding bleeding risks on each case. Created in January 2015, the mass tort alleges that Janssen ... Read More

Woman fights to keep $28M Xarelto jury award

A woman’s near-$28 million jury verdict for injuries suffered while taking the blood thinner Xarelto was reversed last month, but she is fighting to get the compensation she believes she’s entitled to. Lynn Hartman has outlined issues she intends to raise with the Pennsylvania Superior Court in a brief challenging the Philadelphia Court of Common Pleas ruling to eliminate her $27.8 million award, the first win for plaintiffs in a multidistrict litigation accusing Xarelto makers Johnson & Johnson’s Janssen Pharmaceuticals and Bayer of not adequately warning about Xarelto side effects. Hartman’s appeal includes a challenge of Judge Michael Erdos’ statement ... Read More

Common aspirin as effective as Xarelto at preventing blood clots

The pricey blood thinner Xarelto is no better than common aspirin at preventing blood clots in patients who have recently undergone hip or knee replacement surgery, and bleeding risks between the two medications were similar, according to a study published in the New England Journal of Medicine. People who undergo hip or knee replacement surgeries are prone to developing blood clots, or venous thromboemboli (VTE), and are typically given blood thinners prophylactically. The study involved nearly 35,000 patients, all of whom were treated with Xarelto for five days after hip or knee replacement surgery. After five days, about half remained ... Read More